Digest Network Come funziona
Network
/
Società
OK
Non verificato

OKYO Pharma LTD

Di cosa scriviamo

Annunci EconomiciBiotecnologiaFinanzaFondi di investimentoMedicina Salute Benessere

15 comunicati stampa

Guarda tutti i comunicati
19/05/2026
Biotecnologia
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
29/04/2026
Biotecnologia
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
07/04/2026
Biotecnologia
Medicina Salute Benessere
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
19/03/2026
Biotecnologia
Finanza
OKYO Pharma Announces Chairman and Founder Acquires Shares
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
19/03/2026
Biotecnologia
Finanza
OKYO Pharma Announces Director Acquires Shares
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
19/03/2026
Biotecnologia
Medicina Salute Benessere
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
18/03/2026
Biotecnologia
Annunci Economici
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
23/02/2026
Biotecnologia
Medicina Salute Benessere
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
12/02/2026
Biotecnologia
Finanza
Medicina Salute Benessere
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0
12/02/2026
Biotecnologia
Fondi di investimento
OKYO Pharma Announces Public Offering of Ordinary Shares
Fonte
OKYO Pharma LTD
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0